Table of Contents

2019-2024 Global Triptorelin Acetate Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Triptorelin Acetate Consumption 2014-2024
  • 2.1.2 Triptorelin Acetate Consumption CAGR by Region
• 2.2 Triptorelin Acetate Segment by Type
  • 2.2.1 0.1 mg
  • 2.2.2 3 mg
  • 2.2.3 11.25 mg
• 2.3 Triptorelin Acetate Consumption by Type
  • 2.3.1 Global Triptorelin Acetate Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Triptorelin Acetate Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Triptorelin Acetate Sale Price by Type (2014-2019)
• 2.4 Triptorelin Acetate Segment by Application
  • 2.4.1 Male Disease
  • 2.4.2 Female Disease
• 2.5 Triptorelin Acetate Consumption by Application
  • 2.5.1 Global Triptorelin Acetate Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Triptorelin Acetate Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Triptorelin Acetate Sale Price by Application (2014-2019)

3 Global Triptorelin Acetate by Players

• 3.1 Global Triptorelin Acetate Sales Market Share by Players
  • 3.1.1 Global Triptorelin Acetate Sales by Players (2017-2019)
  • 3.1.2 Global Triptorelin Acetate Sales Market Share by Players (2017-2019)
• 3.2 Global Triptorelin Acetate Revenue Market Share by Players
  • 3.2.1 Global Triptorelin Acetate Revenue by Players (2017-2019)
  • 3.2.2 Global Triptorelin Acetate Revenue Market Share by Players (2017-2019)
• 3.3 Global Triptorelin Acetate Sale Price by Players
• 3.4 Global Triptorelin Acetate Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Triptorelin Acetate Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Triptorelin Acetate Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Triptorelin Acetate by Regions

• 4.1 Triptorelin Acetate by Regions
  • 4.1.1 Global Triptorelin Acetate Consumption by Regions
  • 4.1.2 Global Triptorelin Acetate Value by Regions
• 4.2 Americas Triptorelin Acetate Consumption Growth
• 4.3 APAC Triptorelin Acetate Consumption Growth
• 4.4 Europe Triptorelin Acetate Consumption Growth
• 4.5 Middle East & Africa Triptorelin Acetate Consumption Growth

5 Americas

• 5.1 Americas Triptorelin Acetate Consumption by Countries
  • 5.1.1 Americas Triptorelin Acetate Consumption by Countries (2014-2019)
  • 5.1.2 Americas Triptorelin Acetate Value by Countries (2014-2019)
• 5.2 Americas Triptorelin Acetate Consumption by Type
• 5.3 Americas Triptorelin Acetate Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Triptorelin Acetate Consumption by Countries
  • 6.1.1 APAC Triptorelin Acetate Consumption by Countries (2014-2019)
  • 6.1.2 APAC Triptorelin Acetate Value by Countries (2014-2019)
• 6.2 APAC Triptorelin Acetate Consumption by Type
• 6.3 APAC Triptorelin Acetate Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Triptorelin Acetate by Countries
  • 7.1.1 Europe Triptorelin Acetate Consumption by Countries (2014-2019)
  • 7.1.2 Europe Triptorelin Acetate Value by Countries (2014-2019)
• 7.2 Europe Triptorelin Acetate Consumption by Type
• 7.3 Europe Triptorelin Acetate Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Triptorelin Acetate by Countries
  • 8.1.1 Middle East & Africa Triptorelin Acetate Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Triptorelin Acetate Value by Countries (2014-2019)
• 8.2 Middle East & Africa Triptorelin Acetate Consumption by Type
• 8.3 Middle East & Africa Triptorelin Acetate Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Triptorelin Acetate Distributors
• 10.3 Triptorelin Acetate Customer

11 Global Triptorelin Acetate Market Forecast

• 11.1 Global Triptorelin Acetate Consumption Forecast (2019-2024)
• 11.2 Global Triptorelin Acetate Forecast by Regions
  • 11.2.1 Global Triptorelin Acetate Forecast by Regions (2019-2024)
  • 11.2.2 Global Triptorelin Acetate Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Triptorelin Acetate Forecast by Type
• 11.8 Global Triptorelin Acetate Forecast by Application

12 Key Players Analysis

• 12.1 Ipsen
  • 12.1.1 Company Details
  • 12.1.2 Triptorelin Acetate Product Offered
  • 12.1.3 Ipsen Triptorelin Acetate Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Ipsen News
• 12.2 Ferring
  • 12.2.1 Company Details
  • 12.2.2 Triptorelin Acetate Product Offered
  • 12.2.3 Ferring Triptorelin Acetate Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Ferring News
• 12.3 Chengdu Tiantaishan
  • 12.3.1 Company Details
  • 12.3.2 Triptorelin Acetate Product Offered
  • 12.3.3 Chengdu Tiantaishan Triptorelin Acetate Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Chengdu Tiantaishan News
• 12.4 TECNOFARMA
  • 12.4.1 Company Details
  • 12.4.2 Triptorelin Acetate Product Offered
  • 12.4.3 TECNOFARMA Triptorelin Acetate Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 TECNOFARMA News
• 12.5 Changchun Gensci
  • 12.5.1 Company Details
  • 12.5.2 Triptorelin Acetate Product Offered
  • 12.5.3 Changchun Gensci Triptorelin Acetate Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Changchun Gensci News

...

13 Research Findings and Conclusion

Triptorelin Acetate is a peptide formulation for injection that was initially developed and continues to be used mainly in the treatment of advanced metastatic prostate cancer. Additional indications developed subsequently include the treatment of uterine fibroids (a benign tumour of muscle tissues in the uterus), endometriosis (proliferation of endometrial tissue, the mucous membrane that lines the uterine wall outside the reproductive tract) prior to surgery or when surgery is not deemed appropriate, as well as early onset puberty and female infertility (in vitro fertilisation).
The global production of triptorelin acetate is about 2770 k units in 2015, the production region is mainly concentrated in Europe, the biggest three countries are France, Germany and Ireland. The top two companies are Ipsen and Ferring, they occupies about 95% market shares;
Although the production region is very concentration, the consumption region is very dispersion, in 2015, the largest consumption Europe is about 38%, the North America consumes about 12% market share, China occupies about 9% market share, Japan occupies about 8.29% market share.
The production and consumption region is different, the production region is mainly concentrated in Europe, the consumption region is dispersion in all over the world; the countries which do not include in the Europe mainly depends on import.

According to this study, over the next five years the Triptorelin Acetate market will register a 4.7% CAGR in terms of revenue, the global market size will reach US$ 600 million by 2024, from US$ 460 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Triptorelin Acetate business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Triptorelin Acetate market by product type, application, key manufacturers and key regions and countries.

This study considers the Triptorelin Acetate value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
0.1 mg
3 mg
11.25 mg
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Male Disease
Female Disease

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Ipsen
Ferring
Chengdu Tiantaishan
TECNOFARMA
Changchun Gensci
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Triptorelin Acetate consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Triptorelin Acetate market by identifying its various subsegments.
Focuses on the key global Triptorelin Acetate manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Triptorelin Acetate with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Triptorelin Acetate submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.